Evofem Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EVFM and buy or sell other stocks, options, and ETFs commission-free!

About EVFM

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. 

CEO
Saundra L. Pelletier
CEOSaundra L. Pelletier
Employees
37
Employees37
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
37
Employees37

EVFM Key Statistics

Market cap
25.60K
Market cap25.60K
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
53.48K
Average volume53.48K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$196.25
52 Week high$196.25
52 Week low
$0.85
52 Week low$0.85
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.